Ruka hadi maudhui makuu

Condition · 2 treatment paths

Lung Cancer (NSCLC Advanced)

Advanced non-small cell lung cancer is lung cancer that has spread beyond its original area to lymph nodes, the other lung or distant organs. It is usually not curable but can often be controlled for a period.

Severe
Request opinion View roster

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Ilisasishwa mwisho: Jinsi tunavyokusanya na kukagua taarifa

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
2Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About lung cancer (nsclc advanced)

What to know

Symptoms include persistent cough, breathlessness, chest pain, weight loss and coughing blood, or symptoms from where it has spread. Diagnosis uses CT or PET-CT and a biopsy, and tumour testing for mutations such as EGFR, ALK and the PD-L1 level. These results largely decide the best treatment.

Treatment depends on the tumour's molecular profile. Targeted tablets are used when there is a matching mutation, and immunotherapy, with or without chemotherapy, is used when there is not. Chemotherapy remains important, and radiotherapy relieves symptoms such as pain or airway blockage. Supportive and palliative care run alongside. Patients sometimes travel abroad for access to newer targeted drugs or clinical trials.

Pre-flight workup

Tests to have already done

  • Biopsy pathology report including the subtype, with tumour tissue or blocks available for molecular testing.
  • Molecular profiling results for EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, NTRK and PD-L1 expression.
  • CT of the chest and abdomen, PET-CT and MRI of the brain, which are usually requested for staging.
  • Lung function, blood counts, liver and kidney tests and your performance status.
  • Records of treatments already given with dates, scans and side effects.

Second opinion

When to get a second look

  • Molecular testing has not been done or was limited, since results can change the treatment completely.
  • You were advised chemotherapy only, although your tumour may carry a targetable mutation.
  • Your disease has progressed on first treatment and you want to know about next-line options.
  • Brain spread has been found and you want to discuss local treatment options.

Talking to your doctor

Questions to ask

  1. Which molecular changes does my tumour have, and are there tablets that target them?
  2. Is immunotherapy suitable for me, based on PD-L1 and my other conditions?
  3. What is the goal of treatment, and how long might it control the cancer?
  4. What are the common side effects and when should I call for help?
  5. How and how often will treatment response be checked?
  6. What supportive and palliative care is available alongside treatment?

Outlook

Realistic prognosis

Advanced lung cancer is usually not curable, but treatment can control it for months to years. Outcomes have improved markedly where a targetable mutation such as EGFR or ALK is found, or where immunotherapy suits the tumour. Fitness, tumour biology, spread to the brain and response to first treatment influence the outlook. Symptom relief is an important goal throughout.

01 · Specialties

Specialties that treat Lung

Specialists Doctors who treat lung cancer (nsclc advanced) Cross-hospital roster across 1+ relevant specialties. View roster

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For lung cancer (nsclc advanced), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

03 · Treatment paths

Treatment options

All treatments

Where to be treated

Lung Cancer (NSCLC Advanced) treatment by destination

Get a panel match

04 · FAQ

Common questions about lung cancer (nsclc advanced)

Why is gene testing so important?

Some lung cancers have mutations such as EGFR or ALK that respond very well to targeted tablets, often better than to chemotherapy. Testing before treatment ensures you get the most effective drug.

What is immunotherapy?

It is treatment that helps your immune system recognise and attack cancer cells. It can give lasting control in some patients, particularly those with high PD-L1, but can cause immune side effects.

Can advanced lung cancer be cured?

Cure is uncommon, but treatment can control the disease, sometimes for years, and relieve symptoms.

Can I travel during treatment?

Many people can travel between treatment cycles if they feel well. Breathlessness, low oxygen, fluid on the lung or low blood counts may limit flying, so check with your oncologist.

Clinical context

Working up lung cancer (nsclc advanced) properly

A condition like lung cancer (nsclc advanced) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

This lung cancer (nsclc advanced) overview is written by the editorial team from published Oncology sources and lists 2 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
  2. Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
  3. Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
  4. Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Vyanzo vya taarifa za ukurasa huu
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Lung Cancer (NSCLC Advanced)

Continue evaluating lung cancer (nsclc advanced) care

Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating lung cancer (nsclc advanced).

Hatua inayofuata · Lung Cancer (NSCLC Advanced)

Free second opinion on your Lung case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.

Pata makadirio ya bei bureMakadirio ya kina kutoka hospitali zilizoidhinishwa, bila malipo Maoni ya pili ya daktari bureMtaalamu anapitia ripoti zako Ongea na mratibuWhatsApp, barua pepe au simu